ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Partnership Driving Superior Enrollment And Speed In Phase III Trial

  Examine the partnership between CRIO and Sitero, including how it underscores the significant impact of technology in optimizing trial performance and accelerating treatment development.

• How EDC-Based SAE Reporting Reduces Time To Detection And Response

  Serious adverse events (SAEs) play a pivotal role in patient safety during clinical trials, and the right EDC system helps you efficiently track and manage the entire lifecycle of SAE reporting.

• Come To The Dark (Mode) Side

  Many of the decisions made by a product team start as suggestions from a user community of clinical professionals. While planning the development of a recently launched CTMS, a focus group was led where clinical professionals weighed in on potential improvements for a new system.

• Capture Was Step One. Execution Is Step Two.

  Electronic data capture transformed clinical trials, but advancing a study depends on decision workflows that interpret data, coordinate teams, and determine meaningful next actions.

• Reduce The Need To Perform A 12-Lead ECG In Resource Limited Settings

  Remote cardiac monitoring technology is enabling the pharmaceutical industry to shift towards innovative, efficient, and patient-friendly clinical trials.

• From Frustration To Organization: An SSO Platform For Trial Sites

  To reap the benefits of tech innovation, sponsors and sites need a single sign-on (SSO) solution that enables streamlined organization across different trials and clinical systems.

• How Health Information Technology Is Transforming Human Lives

  Here, the authors take a closer look at how these advancements are not just revolutionizing healthcare but also instilling hope for a brighter and healthier future.

• Why Are Sponsor Organizations Using More Than 1 CTMS Solution?

  Explore evolutions in the eClinical market, CTMS use in the outsourcing community, and the difficulty in keeping up with requirements that sponsor organizations, CROs, and clinical trial sites experience regarding their CTMS solutions.

• Will DCTs Finally Democratize Clinical Trials?

  Who wouldn’t rather wear a smartwatch than drive 75 miles to have someone measure their blood pressure? See how DCTs have the capacity to include more people from a broader range of demographics.

• Why Oncology Drug Development Lags In Digital Biomarkers

  Despite technological advances, oncology drug development research has lagged in adopting wearable digital biomarkers. Explore this space's unique challenges and the benefits of wearable technology.